HURA as of Nov 2 · 06:56 ET
HURANasdaqPharmaceutical Preparations

TuHURA Biosciences, Inc. · Brief

Next report

11 days

Nov 13 · before openest.Q3 FY26

Expected move

No implied move.

Implied vs realized

8 reportsHistory
—≥ implied
Oct 21 '24—▼−12.22%—
Apr 1 '25—▼−9.91%—
May 15 '25—▲+2.08%—
Aug 14 '25—▲+10.87%—
Q3 FY25—▲+0.49%—
Q1 FY26—▼−9.50%—
May 15 '26—▲+10.39%—
Q2 FY26—▲+7.39%—
quarterimplied−15%0+15%realized×
Q2 FY26—▲+7.39%—
May '26—▲+10.39%—
Q1 FY26—▼−9.50%—
Q3 FY25—▲+0.49%—
Aug '25—▲+10.87%—
May '25—▲+2.08%—
2 older reports
Apr '25—▼−9.91%—
Oct '24—▼−12.22%—
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Bull & bear

Nov 13 report · est.

Bull2

4disclosed supplier and customer ties in SEC filingsSEC filings
83managers reporting a position in the latest quarterly filings13F · Jun 30 '26

Bear2 of 3

13managers whose positions together make up four fifths of the reported value13F · Jun 30 '26
11 of 17largest reporting managers that cut their stake in the latest quarter13F · Jun 30 '26
AI captions · Sep 28 '26once per report · top 2 per case

Linked exposure

HURA report session

No linked exposure.

Latest changes

30 daysAll changes

No changes.

Your note

privateThesis 0 · Decisions 0 · Observations 0

No thesis.